Dogwood Therapeutics Raises $5 Million in Share Sale at $1.22
The company agreed to sell 4,098,360 common shares to Sealbond for approximately $5 million in gross proceeds. Closing is expected on or before Oct. 29, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.